Clinical Leader Strengthens Editorial Advisory Board

Erie, PA – Clinical Leader, the pharmaceutical industry’s leading online resource for clinical trial analysis and opinion, is dedicated to streamlining the clinical research process by connecting trial sponsors with cutting edge service providers to speed medicines to patients. Our goal is to facilitate connections and improve collaborations by providing valuable information on CROs, sponsors, and advancements in clinical trials.

To ensure readers receive content that is timely and valuable, Clinical Leader relies on the feedback of pharma industry professionals and consultants to guide its focus and direction. Our Editorial Advisory Board, composed of consultants and executives from the pharmaceutical industry, helps guide the direction and focus of our editorial content.

Clinical Leader is proud to announce seven distinguished industry executives who were added to the board in January 2019:

Sandra Dunn, Founder and CEO, Phoenix Molecular Designs

Tina Karunaratne, Director, Clinical & Late Stage Program Management, Astellas Institute for Regenerative Medicine

Wendi Lau, VP, Operational Improvement & Reporting Excellence, Astellas Pharma

John Maffeo, Senior Director, Head of Clinical Operations, TARIS Biomedical

Katie Mazuk, VP, Clinical Insights and Experience, Johnson & Johnson

Mary Stober Murray, Associate Director, Diversity and Patient Engagement, Bristol-Myers Squibb

Valerie Reynaert, Head of Clinical Operations, Americas, GlaxoSmithKline

The inaugural Clinical Leader editorial advisory board was launched in December 2014. The complete editorial advisory board can be seen here.

Clinical Leader thanks these professionals for agreeing to serve and we look forward to working with all of them to ensure our content continues to provide readers with actionable information that will help make their clinical trials more successful.

For more information:

Ed Miseta, Chief Editor

(814) 897-7700 ext. 179

ed.miseta@lifescienceconnect.com